메뉴 건너뛰기




Volumn 110, Issue 5, 2012, Pages 662-665

Evaluation of low-density lipoprotein particle number distribution in patients with type 2 diabetes mellitus with low-density lipoprotein cholesterol <50 mg/dl and non-high-density lipoprotein cholesterol <80 mg/dl

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

EID: 84864917939     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2012.04.046     Document Type: Article
Times cited : (24)

References (13)
  • 1
    • 44649098307 scopus 로고    scopus 로고
    • Lipoprotein management in patients with cardiometabolic risk: Consensus statement from the American Diabetes Association and the American College of Cardiology foundation
    • J.D. Brunzell, M. Davidson, C.D. Furberg, R.B. Goldberg, B.V. Howard, J.H. Stein, J.L. Witztum Lipoprotein management in patients with cardiometabolic risk: Consensus statement from the American Diabetes Association and the American College of Cardiology foundation Diabetes Care 31 2008 811 822
    • (2008) Diabetes Care , vol.31 , pp. 811-822
    • Brunzell, J.D.1    Davidson, M.2    Furberg, C.D.3    Goldberg, R.B.4    Howard, B.V.5    Stein, J.H.6    Witztum, J.L.7
  • 2
    • 34247478090 scopus 로고    scopus 로고
    • State of diabetes care in the United States
    • L. Blonde State of diabetes care in the United States Am J Manag Care 13 suppl 2007 S36 S40
    • (2007) Am J Manag Care , vol.13 , Issue.SUPPL.
    • Blonde, L.1
  • 3
    • 0037126526 scopus 로고    scopus 로고
    • Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): Final report
    • Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): final report Circulation 106 2002 3143 3421
    • (2002) Circulation , vol.106 , pp. 3143-3421
  • 4
    • 61349099439 scopus 로고    scopus 로고
    • Diagnosis and classification of diabetes mellitus (position statement)
    • American Diabetes Association
    • American Diabetes Association Diagnosis and classification of diabetes mellitus (position statement) Diabetes Care 32 2009 S62 S67
    • (2009) Diabetes Care , vol.32
  • 5
    • 0037840242 scopus 로고    scopus 로고
    • MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: A randomized placebo-controlled trial
    • Heart Protection Study Collaborative Group
    • Heart Protection Study Collaborative Group MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomized placebo-controlled trial Lancet 361 2003 2005 2016
    • (2003) Lancet , vol.361 , pp. 2005-2016
  • 6
    • 33750804460 scopus 로고    scopus 로고
    • Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy
    • E. Jeyarajah, W. Cromwell, J. Otvos Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy Clin Lab Med 26 2006 847 870
    • (2006) Clin Lab Med , vol.26 , pp. 847-870
    • Jeyarajah, E.1    Cromwell, W.2    Otvos, J.3
  • 7
    • 0015348189 scopus 로고
    • Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
    • W.T. Friedewald, R.I. Levy, D.S. Fredrickson Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge Clin Chem 18 1972 499 502
    • (1972) Clin Chem , vol.18 , pp. 499-502
    • Friedewald, W.T.1    Levy, R.I.2    Fredrickson, D.S.3
  • 8
    • 79952515201 scopus 로고    scopus 로고
    • Clinical implications of discordance between low-density lipoprotein cholesterol and particle number
    • J.D. Otvos, S. Mora, I. Shalaurova, P. Greenland, R.H. Mackey, D.C. Goff Clinical implications of discordance between low-density lipoprotein cholesterol and particle number J Clin Lipidol 5 2011 105 113
    • (2011) J Clin Lipidol , vol.5 , pp. 105-113
    • Otvos, J.D.1    Mora, S.2    Shalaurova, I.3    Greenland, P.4    MacKey, R.H.5    Goff, D.C.6
  • 9
    • 2542461241 scopus 로고    scopus 로고
    • Optimal low-density lipoprotein is 50 to 70 mg/dl: Lower is better and physiologically normal
    • J.H. O'Keefe, L. Cordain, W.H. Harris, R.M. Moe, R. Vogel Optimal low-density lipoprotein is 50 to 70 mg/dl: lower is better and physiologically normal J Am Call Cardiol 43 2004 2142 2146
    • (2004) J Am Call Cardiol , vol.43 , pp. 2142-2146
    • O'Keefe, J.H.1    Cordain, L.2    Harris, W.H.3    Moe, R.M.4    Vogel, R.5
  • 10
    • 35048833627 scopus 로고    scopus 로고
    • LDL particle number is highly heterogeneous among patients with type 2 diabetes at an LDL cholesterol target goal <100 mg/dl
    • W.C. Cromwell, J.D. Otvos LDL particle number is highly heterogeneous among patients with type 2 diabetes at an LDL cholesterol target goal <100 mg/dl Am J Cardiol 98 2006 1599 1602
    • (2006) Am J Cardiol , vol.98 , pp. 1599-1602
    • Cromwell, W.C.1    Otvos, J.D.2
  • 11
    • 36749101948 scopus 로고    scopus 로고
    • LDL particle number and risk of future cardiovascular disease in the Framingham Offspring Study - Implications for LDL management
    • W.C. Cromwell, J.D. Otvos, M. Keyes, M. Pencina, L. Sullivan, R. Vasan, P. Wilson, R. D'Agostino LDL particle number and risk of future cardiovascular disease in the Framingham Offspring Study - implications for LDL management J Clin Lipidol 1 2007 583 592
    • (2007) J Clin Lipidol , vol.1 , pp. 583-592
    • Cromwell, W.C.1    Otvos, J.D.2    Keyes, M.3    Pencina, M.4    Sullivan, L.5    Vasan, R.6    Wilson, P.7    D'Agostino, R.8


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.